Furthermore, intraperitoneal administration of AMD3100 (10 mg/kg), a CXCR4 inhibitor, to LLC1 tumor‐bearing mice resulted in the dispersal of CD8+ T cells from CAF‐dense regions throughout the tumors (Figure 1D). The gene discussed is CD8A; the disease is neoplasm.